Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1997 1
1998 4
2005 2
2009 1
2010 3
2011 2
2012 1
2013 1
2014 2
2015 3
2017 1
2019 2
2020 2
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Première étude randomisée, multicentrique, contrôlée en double insu, étudiant l'efficacité du sulforaphane versus placebo chez des patients atteints d'un cancer de la prostate en échappement biologique après prostatectomie totale±radiothérapie externe.
Cipolla B, Mandron E, Lefort J, Coadou Y, Negra ED, Corbel L, Le Scodan R, Mottet N. Cipolla B, et al. Among authors: mandron e. Prog Urol. 2014 Nov;24(13):820-1. doi: 10.1016/j.purol.2014.08.083. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461609 French. No abstract available.
Résultats économiques de Propenlap, étude prospective multicentrique comparant les voies ouvertes et mini-invasives de la prostatectomie totale.
Durand-Zaleski I, Rabetrano H, Devonec M, Mandron E, Soulie M, De la Taille A, Benoit G, Mottet N, Gasman D, Dore B, Zerbib M, Vaessen C, Irani J, Lebret T, Colombel M, Lechevallier E, Bastuji-Garin S, Allory Y, Abbou C, Rischmann P, Salomon L. Durand-Zaleski I, et al. Among authors: mandron e. Prog Urol. 2015 Nov;25(13):742. doi: 10.1016/j.purol.2015.08.054. Prog Urol. 2015. PMID: 26544250 French. No abstract available.
Étude prospective multicentrique comparant les voies ouverte et mini-invasive de la prostatectomie totale (Propenlap : résultats fonctionnels).
Salomon L, Bastuji-Garin S, Soulie M, Devonec M, Boutin E, Mandron E, Benoit G, Rischmann P, Mottet N, Gasman D, Irani J, De la Taille A, Zerbib M, Vaesen C, Dore B, Lebret T, Colombel M, Lechevallier E, Gregoire L, Allory Y, Abbou C. Salomon L, et al. Among authors: mandron e. Prog Urol. 2015 Nov;25(13):793. doi: 10.1016/j.purol.2015.08.154. Prog Urol. 2015. PMID: 26544349 French. No abstract available.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Pfister C, Gravis G, Flechon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulie M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Lancet Oncol. 2024 Feb;25(2):255-264. doi: 10.1016/S1470-2045(23)00587-9. Epub 2023 Dec 21. Lancet Oncol. 2024. PMID: 38142702 Clinical Trial.
Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy.
Cipolla BG, Mandron E, Lefort JM, Coadou Y, Della Negra E, Corbel L, Le Scodan R, Azzouzi AR, Mottet N. Cipolla BG, et al. Among authors: mandron e. Cancer Prev Res (Phila). 2015 Aug;8(8):712-9. doi: 10.1158/1940-6207.CAPR-14-0459. Epub 2015 May 12. Cancer Prev Res (Phila). 2015. PMID: 25968598 Clinical Trial.
29 results